Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Rocci

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Cancer Cell|August 10, 2016
RETRACTED: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma DevelopmentFlavia Pichiorri, Sung-Suk Suh, Alberto Rocci, et al.
Cancer Cell|October 28, 2022
Retraction Notice to: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma DevelopmentFlavia Pichiorri, Sung-Suk Suh, Alberto Rocci, et al.
Journal of Proteomics|January 18, 2016
Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markersSean W Harshman, Alessandro Canella, Paul D Ciarlariello, et al.
Oncotarget|October 26, 2016
Minimal residual disease after transplantation or lenalidomide-based consolidation in myeloma patients: a prospective analysisStefania Oliva, Manuela Gambella, Milena Gilestro, et al.
JCI Insight|October 9, 2019
MiR-16 regulates crosstalk in NF-κB tolerogenic inflammatory signaling between myeloma cells and bone marrow macrophagesJihane Khalife, Jayeeta Ghose, Marianna Martella, et al.
British Journal of Haematology|January 24, 2014
MET dysregulation is a hallmark of aggressive disease in multiple myeloma patientsAlberto Rocci, Manuela Gambella, Simona Aschero, et al.
The Journal of Experimental Medicine|April 24, 2013
In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulationFlavia Pichiorri, Dario Palmieri, Luciana De Luca, et al.
The Journal of Experimental Medicine|January 21, 2017
Correction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulationFlavia Pichiorri, Dario Palmieri, Luciana De Luca, et al.
The Journal of Experimental Medicine|June 30, 2026
Retraction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulationFlavia Pichiorri, Dario Palmieri, Luciana De Luca, et al.
Mechanisms of Ageing and Development|June 13, 2012
Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: evidence for premature aging of the myeloid compartmentChiara Lobetti-Bodoni, Dario Ferrero, Elisa Genuardi, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Cancer Cell|August 10, 2016
RETRACTED: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma DevelopmentFlavia Pichiorri, Sung-Suk Suh, Alberto Rocci, et al.
Cancer Cell|October 28, 2022
Retraction Notice to: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma DevelopmentFlavia Pichiorri, Sung-Suk Suh, Alberto Rocci, et al.
Journal of Proteomics|January 18, 2016
Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markersSean W Harshman, Alessandro Canella, Paul D Ciarlariello, et al.
Oncotarget|October 26, 2016
Minimal residual disease after transplantation or lenalidomide-based consolidation in myeloma patients: a prospective analysisStefania Oliva, Manuela Gambella, Milena Gilestro, et al.
JCI Insight|October 9, 2019
MiR-16 regulates crosstalk in NF-κB tolerogenic inflammatory signaling between myeloma cells and bone marrow macrophagesJihane Khalife, Jayeeta Ghose, Marianna Martella, et al.
British Journal of Haematology|January 24, 2014
MET dysregulation is a hallmark of aggressive disease in multiple myeloma patientsAlberto Rocci, Manuela Gambella, Simona Aschero, et al.
The Journal of Experimental Medicine|April 24, 2013
In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulationFlavia Pichiorri, Dario Palmieri, Luciana De Luca, et al.
The Journal of Experimental Medicine|January 21, 2017
Correction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulationFlavia Pichiorri, Dario Palmieri, Luciana De Luca, et al.
The Journal of Experimental Medicine|June 30, 2026
Retraction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulationFlavia Pichiorri, Dario Palmieri, Luciana De Luca, et al.
Mechanisms of Ageing and Development|June 13, 2012
Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: evidence for premature aging of the myeloid compartmentChiara Lobetti-Bodoni, Dario Ferrero, Elisa Genuardi, et al.
Pageof 4